Compounds > nadp
Page last updated: 2024-08-17

nadp and Leukemia, Myeloid, Acute

nadp has been researched along with Leukemia, Myeloid, Acute in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's6 (42.86)24.3611
2020's4 (28.57)2.80

Authors

AuthorsStudies
Chen, C; Chen, W; Dan, S; Huang, D; Jiang, Y; Lai, X; Liu, L; Xie, L; Yang, Y; Yu, Z; Zhang, Y; Zhao, Y; Zheng, J1
Borate, U; Burd, A; Cai, F; Cai, SF; Cao, H; Chen, M; Chen, W; Chung, SS; Collins, RH; DeBerardinis, RJ; Dickerson, KE; Gong, L; Gu, Z; Kalkan, FN; Kaphle, P; Kim, YJ; Liu, X; Liu, Y; Lyu, J; Madanat, YF; Mims, AS; Ni, M; Patel, P; Stephens, H; Xu, J; Yin, CC; You, MJ; Zhang, Y1
Cardinali, V; Cerchione, C; Falini, B; Martelli, MP; Martinelli, G; Martino, G1
Arellano, M; Blum, WG; Boggon, TJ; Chen, D; Chen, J; Dong, L; Elf, SE; Famulare, CA; Fan, H; Gao, X; He, C; Le Beau, M; Levine, RL; Li, Y; Lonial, S; Mao, H; Odenike, O; Stock, W; Su, R; Wang, M; Wu, R; Xia, S; Zhang, R; Zhu, AC1
Heaster, TM; Hiebert, SW; Skala, MC; Walsh, AJ; Zhao, Y1
Cajka, T; Carraway, KL; Fiehn, O; Hatakeyama, J; Showalter, MR; VanderVorst, K1
Adane, B; Ashton, JM; Crooks, PA; D'Alessandro, A; De, S; Gutman, JA; Hagen, FK; Hansen, KC; Jordan, CT; Khan, N; Minhajuddin, M; Nemkov, T; Pei, S; Pollyea, DA; Smith, C; Stevens, BM; Yadav, VK1
Li, X; Wang, TS; Wang, YP; Xu, SN1
Bittinger, MA; Cairns, RA; Dang, L; Driggers, EM; Fantin, VR; Gross, S; Jang, HG; Jin, S; Mak, TW; Minden, MD; Sasaki, M; Schenkein, DP; Su, SM1
Abdel-Wahab, O; Levine, RL1
Korytowska, A; Kostrzewa-Nowak, D; Paine, MJ; Piotrowska, S; Serwatka, K; Tarasiuk, J; Wolf, CR1
Belfiore, F; Borzi, V; Napoli, E; Rabuazzo, AM; Vecchio, LL1
Luganova, IS; Seitz, JF1
Kowalewski, J1

Reviews

1 review(s) available for nadp and Leukemia, Myeloid, Acute

ArticleYear
Enasidenib and ivosidenib in AML.
    Minerva medica, 2020, Volume: 111, Issue:5

    Topics: Aminopyridines; Antineoplastic Agents; Cell Differentiation; Clinical Trials as Topic; Glutarates; Glycine; Humans; Isocitrate Dehydrogenase; Isocitrates; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Multicenter Studies as Topic; Mutation, Missense; NADP; Pyridines; Syndrome; Triazines

2020

Other Studies

13 other study(ies) available for nadp and Leukemia, Myeloid, Acute

ArticleYear
NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells.
    Cell reports, 2022, 04-05, Volume: 39, Issue:1

    Topics: Animals; Bone Marrow; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Methotrexate; Mice; NADP

2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.
    Cancer discovery, 2023, 01-09, Volume: 13, Issue:1

    Topics: Amino Acids; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; NADP

2023
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells.
    Molecular cell, 2021, 09-16, Volume: 81, Issue:18

    Topics: Acetyl-CoA C-Acetyltransferase; Acetylation; Animals; Antineoplastic Agents; Female; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Lysine; Male; Mice; Mice, Inbred NOD; Mutation; NADP; Nuclear Proteins; Phosphorylation; Polymorphism, Single Nucleotide; Primary Cell Culture; Protein Binding; Protein Processing, Post-Translational; Protein-Tyrosine Kinases

2021
Autofluorescence imaging identifies tumor cell-cycle status on a single-cell level.
    Journal of biophotonics, 2018, Volume: 11, Issue:1

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Discriminant Analysis; Flavin-Adenine Dinucleotide; Humans; Least-Squares Analysis; Leukemia, Myeloid, Acute; NADP; Optical Imaging; Single-Cell Analysis

2018
Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
    eLife, 2017, 06-27, Volume: 6

    Topics: Biotransformation; Glutarates; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Mutant Proteins; NADP; Tumor Cells, Cultured

2017
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
    The Journal of biological chemistry, 2016, Oct-14, Volume: 291, Issue:42

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Male; NADP; Neoplasm Proteins; Neoplastic Stem Cells; NF-E2-Related Factor 2; Sesquiterpenes; Sirolimus; Up-Regulation

2016
SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation.
    Scientific reports, 2016, 09-02, Volume: 6

    Topics: Cell Line, Tumor; Cell Proliferation; Gene Knockdown Techniques; Glucosephosphate Dehydrogenase; Humans; Leukemia, Myeloid, Acute; NADP; Sirtuin 2

2016
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.
    The Journal of experimental medicine, 2010, Feb-15, Volume: 207, Issue:2

    Topics: Catalysis; Glutarates; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Mutation; NADP; Recombinant Proteins

2010
Metabolism and the leukemic stem cell.
    The Journal of experimental medicine, 2010, Apr-12, Volume: 207, Issue:4

    Topics: Animals; Cholecalciferol; Glutarates; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Isocitrate Dehydrogenase; JNK Mitogen-Activated Protein Kinases; Leukemia; Leukemia, Myeloid, Acute; Models, Biological; Mutation, Missense; NADP; Neoplastic Stem Cells; Reactive Oxygen Species

2010
Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells.
    Cancer letters, 2007, Jan-08, Volume: 245, Issue:1-2

    Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Spectrophotometry

2007
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.
    Clinical chemistry, 1975, Volume: 21, Issue:7

    Topics: Alanine Transaminase; Aspartate Aminotransferases; ATP Citrate (pro-S)-Lyase; Glucosephosphate Dehydrogenase; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Malate Dehydrogenase; NADP; Phosphogluconate Dehydrogenase

1975
The biochemical identification of blood and bone marrow cells of patients with acute leukemia.
    Cancer research, 1968, Volume: 28, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Cells; Deoxyuridine; Female; Glucosephosphate Dehydrogenase; Glucosyltransferases; Glycogen; Glycolysis; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; NADP; Nucleosides; Oxygen Consumption; Phosphogluconate Dehydrogenase; Phosphotransferases; Polycythemia; Uridine

1968
[Morphological and cytochemical studies of inflammatory exudate cells and peripheral blood cells in healthy persons and leukaemic patients].
    Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 1967, Volume: 22

    Topics: Adult; Aged; Esterases; Exudates and Transudates; Female; Glycogen; Histocytochemistry; Humans; Inflammation; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lipids; Male; Middle Aged; NADP; Phagocytosis; Phosphoric Monoester Hydrolases; Skin Window Technique; Succinate Dehydrogenase

1967